Pterygium as a Potential Ocular Manifestation of Morphea: A Case Report and Pathogenic Hypothesis

Julia Woźna; Paweł Pazdrowski; Celina Helak-Łapaj; Maksymilian Markwitz; Adriana Polańska; Marcin Stopa; Aleksandra Dańczak-Pazdrowska

doi:10.5114/dr.2025.153630

eISSN: 2084-9893
ISSN: 0033-2526

Dermatology Review/Przegląd Dermatologiczny

Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

5/2025
vol. 112

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

Opis przypadku

Pterygium as a Potential Ocular Manifestation of Morphea: A Case Report and Pathogenic Hypothesis

Julia Woźna

^{1, 2}

,

Paweł Pazdrowski

^{1, 3}

,

Celina Helak-Łapaj

³

,

Maksymilian Markwitz

²

,

Adriana Polańska

⁴

,

Marcin Stopa

³

,

Aleksandra Dańczak-Pazdrowska

²

Doctoral School, Poznan University of Medical Sciences, Poznan, Poland
Department of Dermatology, Poznan University of Medical Sciences, Poznana, Poland
Department of Ophthalmology, Chair of Ophthalmology and Optometry, Poznan University of Medical Sciences, Poznan, Poland
Department of Dermatology and Venerology, Poznan University of Medical Sciences, Poznan, Poland

Dermatol Rev/Przegl Dermatol 2025, 112, 336-339

DOI: https://doi.org/10.5114/dr.2025.153630

Data publikacji online: 2025/12/30

Plik artykułu:

- Pterygium.pdf [0.16 MB]

Pobierz cytowanie

Metryki PlumX:

1. Knobler R., Moinzadeh P., Hunzelmann N., Kreuter A., Cozzio A., Mouthon L., et al.: European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin. Part 1: localized scleroderma, systemic sclerosis and overlap syndromes. J Eur Acad Dermatol Venereol 2017, 31, 1401-1424.

2. Krasowska D., Rudnicka L., Dańczak-Pazdrowska A., Chodorowska G., Woźniacka A., Lis-Święty A., et al.: Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Dermatol Rev 2019, 106, 333-353.

3. Giuggioli D., Colaci M., Cocchiara E., Spinella A., Lumetti F., Ferri C.: Erratum to “From localized scleroderma to systemic sclerosis: coexistence or possible evolution.” Dermatol Res Pract 2018, 2018, 1.

4. Wolska-Gawron K., Krasowska D.: Localized scleroderma – classification and tools used for the evaluation of tissue damage and disease activity/severity. Dermatol Rev 2017, 104, 269-289.

5. Asano Y., Fujimoto M., Ishikawa O., Sato S., Jinnin M., Takehara K., et al.: Diagnostic criteria, severity classification and guidelines of localized scleroderma. J Dermatol 2018, 45, 755-780.

6. Tollefson M.M., Witman P.M.: En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007, 56, 257-263.

7. Weibel L., Harper J.I.: Linear morphoea follows Blaschko’s lines. Br J Dermatol 2008, 159, 175-181.

8. Mears K.A., Servat J.J., Black E.H.: Linear scleroderma en coup de sabre affecting the upper eyelid and lashes. Graefes Arch Clin Exp Ophthalmol 2012, 250, 1097-1099.

9. Kreuter A., Mitrakos G., Hofmann S.C., Lehmann P., Sticherling M., Krieg T., et al.: Localized scleroderma of the head and face area: a retrospective cross-sectional study of 96 patients from 5 german tertiary referral centres. Acta Derm Venereol 2018, 98, 603-605.

10. Bucher F., Fricke J., Neugebauer A., Cursiefen C., Heindl L.M.: Ophthalmological manifestations of Parry-Romberg syndrome. Surv Ophthalmol 2016, 61, 693-701.

11. Fledelius H.C., Danielsen P.L., Ullman S.: Ophthalmic findings in linear scleroderma manifesting as facial en coup de sabre. Eye 2018, 32, 1688-1696.

12. Stein T., Cieplewicz-Guźla P., Iżykowska K., Pieniawska M., Żaba R., Dańczak-Pazdrowska A., et al.: What is new in morphea – narrative review on molecular aspects and new targeted therapies. J Clin Med 2024, 13, 7134.

13. Saracino A.M., Kelberman D., Otto G.W., Gagunashvili A., Abraham D.J., Denton C.P.: Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies. Arch Dermatol Res 2023, 315, 2035-2056.

14. Cao D., Ng T.K., Yip Y.W.Y., Young A.L., Pang C.P., Chu W.K., et al.: p53 inhibition by MDM2 in human pterygium. Exp Eye Res 2018, 175, 142-147.

15. Tsai Y.Y., Chang K.C., Lin C.L., Lee H., Tsai F.J., Cheng Y.W., et al.: p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature. Cornea 2005, 24, 583-586.

16. Chu W.K., Choi H.L., Bhat A.K., Jhanji V.: Pterygium: new insights. Eye 2020, 34, 1047-1050.

17. Safi H., Kheirkhah A., Mahbod M., Molaei S., Hashemi H., Jabbarvand M.: Correlations between histopathologic changes and clinical features in pterygia. J Ophthalmic Vis Res 2016, 11, 153-158.

Copyright: © 2025 Polish Dermatological Association. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Indeks osobowy

Pterygium as a Potential Ocular Manifestation of Morphea: A Case Report and Pathogenic Hypothesis

Julia Woźna 1, 2 , Paweł Pazdrowski 1, 3 , Celina Helak-Łapaj 3 , Maksymilian Markwitz 2 , Adriana Polańska 4 , Marcin Stopa 3 , Aleksandra Dańczak-Pazdrowska 2

Julia Woźna

^{1, 2}

,

Paweł Pazdrowski

^{1, 3}

,

Celina Helak-Łapaj

³

,

Maksymilian Markwitz

²

,

Adriana Polańska

⁴

,

Marcin Stopa

³

,

Aleksandra Dańczak-Pazdrowska

²